BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hepatitis
,
Hypothalamus
,
Anticancer prodrugs
,
Ciprofibrate
,
rs2230926
,
PRKCA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
OR1-64
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Thrombosis
Platelet count below reference range
Atopic dermatitis
Thyroid cancer
Platelet disorder
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
FBLN5 protein, human
styrene oxide
Macrocyclic Compounds
Ions
emtricitabine
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
IKZF3
PARP2
BAZ1B
VHL
NR3C1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Towards the convergent therapeutic potential of G protein-coupled receptors in autism spectrum disor…
Driver and novel genes correlated with metastasis of non-small cell lung cancer: A comprehensive ana…
Combined Effect of Famine Exposure and Obesity Parameters on Hypertension in the Midaged and Older A…
Elevated Fasting Blood Glucose Is Predictive of Poor Outcome in Non-Diabetic Stroke Patients: A Sub-…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for OR1-64
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ